Anthony Fauci is an American physician-scientist who led the National Institute of Allergy and Infectious Diseases from 1984 ...

Phase III trial shows majority of patients become attack-free without ongoing meds ...

The EU is poised to ease restrictions on crops developed using Novel Genetic Techniques. While supporters say the technology ...

It's a "gateway to embryo editing to do enhancements." The post Scientists Concerned Latest Gene Editing of Human Embryos ...

CRISPR Therapeutics (NasdaqGM:CRSP) filed a large shelf registration, creating capacity to issue new securities over time.

A new scientific paper published last week by Dr. Dieter Egli and his genetics research team at Columbia University examines ...

A Phase 3 trial found a one-time CRISPR gene-editing therapy reduced hereditary angioedema attacks by 87%, with most patients ...

Florida's citrus industry is turning to gene editing in hopes of outsmarting citrus greening after years of sprays and trials ...

Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) stock is trading higher on Monday on additional positive findings from its global ...

Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first Phase III study of an in vivo CRISPR therapy. In this large-scale, double-blind trial, 80 ...

COMMENTARY: Why is this latest development generally being hailed as a scientific milestone rather than a giant ethical ...